Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission

被引：15

作者：

Giuliano, M

Palmisano, L

Galluzzo, CM

Amici, R

Germinario, E

Okong, P

Kituuka, P

Mmirro, F

Magoni, M

Vella, S

机构：

[1] Ist Super Sanita, Virol Lab, I-00161 Rome, Italy

[2] St Francis Nsambya Hosp, Kampala, Uganda

[3] Mulago Hosp, Kampala, Uganda

来源：

AIDS | 2003年 / 17卷 / 10期

关键词：

D O I：

10.1097/00002030-200307040-00022

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Two zidovudine/lamivudine regimens for the prevention of HIV perinatal transmission were studied for the selection of resistance mutations. The M184V mutation was detected one week after delivery in six out of fifty women (12%) who received the regimen prepartum, intrapartum and postpartum, and was no longer present 3 months later. No nucleoside reverse transcriptase inhibitor resistance-associated mutations were detected in 50 women who received zidovudine/lamivudine intrapartum and postpartum only. No association with the risk of perinatal transmission was found.

引用

页码：1570 / 1572

页数：3

共 6 条

[1]

Burke A, 2002, ANTIVIR THER, V7, pS99

[2] Impact of human immunodeficiency virus type 1 (HIV-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent HIV-1 vertical transmission (HIV Network for Prevention Trials 012 study) [J].

Eshleman, SH ;

Becker-Pergola, G ;

Deseyve, M ;

Guay, LA ;

Mracna, M ;

Fleming, T ;

Cunningham, S ;

Musoke, P ;

Mmiro, F ;

Jackson, JB .

JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (07) :914-917

[3] Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012) [J].

Eshleman, SH ;

Mracna, M ;

Guay, LA ;

Deseyve, M ;

Cunningham, S ;

Mirochnick, M ;

Musoke, P ;

Fleming, T ;

Fowler, MG ;

Mofenson, LM ;

Mmiro, F ;

Jackson, JB .

AIDS, 2001, 15 (15) :1951-1957

[4]

FIETTE P, 2001, 8 EUR C CLIN ASP TRE

[5] Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1 [J].

Mandelbrot, L ;

Landreau-Mascaro, A ;

Rekacewicz, C ;

Berrebi, A ;

Bénifla, JL ;

Burgard, M ;

Lachassine, E ;

Barret, B ;

Chaix, ML ;

Bongain, A ;

Ciraru-Vigneron, N ;

Crenn-Hébert, C ;

Delfraissy, JF ;

Rouzioux, C ;

Mayaux, MJ ;

Blanche, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (16) :2083-2093

[6]

Saba J, 2002, LANCET, V359, P1178

← 1 →